International Journal of Endocrinology and Metabolism

Published by: Kowsar

Effects of the Hydroalcoholic Extract of Zingiber officinale on Arginase I Activity and Expression in the Retina of Streptozotocin-Induced Diabetic Rats

Nasrin Lamuchi-Deli 1 , Mohammad Aberomand 1 , Hossein Babaahmadi-Rezaei 1 and Ghorban Mohammadzadeh 2 , *
Authors Information
1 Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Hyperlipidemia Research Center, Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • International Journal of Endocrinology and Metabolism: April 2017, 15 (2); e42161
  • Published Online: February 13, 2017
  • Article Type: Research Article
  • Received: September 11, 2016
  • Revised: January 23, 2017
  • Accepted: February 1, 2017
  • DOI: 10.5812/ijem.42161

To Cite: Lamuchi-Deli N, Aberomand M, Babaahmadi-Rezaei H, Mohammadzadeh G. Effects of the Hydroalcoholic Extract of Zingiber officinale on Arginase I Activity and Expression in the Retina of Streptozotocin-Induced Diabetic Rats, Int J Endocrinol Metab. 2017 ; 15(2):e42161. doi: 10.5812/ijem.42161.

Copyright © 2017, Research Institute For Endocrine Sciences and Iran Endocrine Society. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Patel C, Rojas M, Narayanan SP, Zhang W, Xu Z, Lemtalsi T, et al. Arginase as a mediator of diabetic retinopathy. Front Immunol. 2013; 4: 173[DOI][PubMed]
  • 2. Yao L, Chandra S, Toque HA, Bhatta A, Rojas M, Caldwell RB, et al. Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout. Cardiovasc Res. 2013; 97(3): 509-19[DOI][PubMed]
  • 3. Shemyakin A, Kovamees O, Rafnsson A, Bohm F, Svenarud P, Settergren M, et al. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus. Circulation. 2012; 126(25): 2943-50[DOI][PubMed]
  • 4. Kovamees O, Shemyakin A, Pernow J. Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus. PLoS One. 2014; 9(7)[DOI][PubMed]
  • 5. Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001; 104(4): 448-54[PubMed]
  • 6. Lefer DJ, Jones SP, Girod WG, Baines A, Grisham MB, Cockrell AS, et al. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol. 1999; 276(6 Pt 2)-50[PubMed]
  • 7. Romero MJ, Iddings JA, Platt DH, Ali MI, Cederbaum SD, Stepp DW, et al. Diabetes-induced vascular dysfunction involves arginase I. Am J Physiol Heart Circ Physiol. 2012; 302(1)-66[DOI][PubMed]
  • 8. Morris SJ. Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr. 2002; 22: 87-105[DOI][PubMed]
  • 9. Miyanaka K, Gotoh T, Nagasaki A, Takeya M, Ozaki M, Iwase K, et al. Immunohistochemical localization of arginase II and other enzymes of arginine metabolism in rat kidney and liver. Histochem J. 1998; 30(10): 741-51[PubMed]
  • 10. Elms SC, Toque HA, Rojas M, Xu Z, Caldwell RW, Caldwell RB. The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes. Diabetologia. 2013; 56(3): 654-62[DOI][PubMed]
  • 11. Cohen RA, Tong X. Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. J Cardiovasc Pharmacol. 2010; 55(4): 308-16[PubMed]
  • 12. Tabit CE, Chung WB, Hamburg NM, Vita JA. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord. 2010; 11(1): 61-74[DOI][PubMed]
  • 13. Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, Champion HC. Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun. 2001; 283(4): 923-7[DOI][PubMed]
  • 14. Jiang M, Jia L, Jiang W, Hu X, Zhou H, Gao X, et al. Protein disregulation in red blood cell membranes of type 2 diabetic patients. Biochem Biophys Res Commun. 2003; 309(1): 196-200[PubMed]
  • 15. Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res. 2013; 98(3): 334-43[DOI][PubMed]
  • 16. Bachetti T, Comini L, Francolini G, Bastianon D, Valetti B, Cadei M, et al. Arginase pathway in human endothelial cells in pathophysiological conditions. J Mol Cell Cardiol. 2004; 37(2): 515-23[DOI][PubMed]
  • 17. Narayanan SP, Rojas M, Suwanpradid J, Toque HA, Caldwell RW, Caldwell RB. Arginase in retinopathy. Prog Retin Eye Res. 2013; 36: 260-80[DOI][PubMed]
  • 18. Caldwell RB, Zhang W, Romero MJ, Caldwell RW. Vascular dysfunction in retinopathy-an emerging role for arginase. Brain Res Bull. 2010; 81(2-3): 303-9[DOI][PubMed]
  • 19. Li Y, Tran VH, Duke CC, Roufogalis BD. Preventive and protective properties of Zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review. Evid Based Complement Alternat Med. 2012; 2012: 1-10
  • 20. Rahmani AH, Shabrmi FM, Aly SM. Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities. Int J Physiol Pathophysiol Pharmacol. 2014; 6(2): 125-36[PubMed]
  • 21. Abdulrazaq NB, Cho MM, Win NN, Zaman R, Rahman MT. Beneficial effects of ginger (Zingiber officinale) on carbohydrate metabolism in streptozotocin-induced diabetic rats. Br J Nutr. 2012; 108(7): 1194-201[DOI][PubMed]
  • 22. Saraswat M, Suryanarayana P, Reddy PY, Patil MA, Balakrishna N, Reddy GB. Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats. Mol Vis. 2010; 16: 1525-37[PubMed]
  • 23. Faried MA, Mansour FK, Zolfakar AS, El-Kholy WB. Protective Role of Ginger on the Induced Diabetic Retinopathy in Adult Albino Rats. J Am Sci. 2014; 10(10): 134-52
  • 24. Kato A, Higuchi Y, Goto H, Kizu H, Okamoto T, Asano N, et al. Inhibitory effects of Zingiber officinale Roscoe derived components on aldose reductase activity in vitro and in vivo. J Agric Food Chem. 2006; 54(18): 6640-4[DOI][PubMed]
  • 25. Tzeng TF, Liou SS, Chang CJ, Liu IM. Zerumbone, a tropical ginger sesquiterpene, ameliorates streptozotocin-induced diabetic nephropathy in rats by reducing the hyperglycemia-induced inflammatory response. Nutr Metab (Lond). 2013; 10(1): 64[DOI][PubMed]
  • 26. Bordbar H, Esmaeilpour T, Dehghani F, Panjehshahin MR. Stereological study of the effect of ginger's alcoholic extract on the testis in busulfan-induced infertility in rats. Iran J Reprod Med. 2013; 11(6): 467-72[PubMed]
  • 27. Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci. 2007; 48(11): 5152-9[DOI][PubMed]
  • 28. Eleazu CO, Iroaganachi M, Okafor PN, Ijeh ,I, Eleazu KC. Ameliorative Potentials of Ginger (Z. officinale Roscoe) on Relative Organ Weights in Streptozotocin induced Diabetic Rats. Int J Biomed Sci. 2013; 9(2): 82-90[PubMed]
  • 29. Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr. 2006; 96(4): 660-6[PubMed]
  • 30. Zafar M, Naeem-ul-Hassan Naqvi S. Effects of STZ-Induced Diabetes on the Relative Weights of Kidney, Liver and Pancreas in Albino Rats: A Comparative Study. Int J Morphol. 2010; 28(1)[DOI]
  • 31. Iranloye BO, Arikawe AP, Rotimi G, Sogbade AO. Anti-diabetic and anti-oxidant effects of Zingiber officinale on alloxan-induced and insulin-resistant diabetic male rats. Niger J Physiol Sci. 2011; 26(1): 89-96[PubMed]
  • 32. Akhani SP, Vishwakarma SL, Goyal RK. Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. J Pharm Pharmacol. 2004; 56(1): 101-5[DOI][PubMed]
  • 33. Heimes K, Feistel B, Verspohl EJ. Impact of the 5-HT3 receptor channel system for insulin secretion and interaction of ginger extracts. Eur J Pharmacol. 2009; 624(1-3): 58-65[DOI][PubMed]
  • 34. Salim KS. Hypoglycemic Property of Z. officinale and Green Tea and their Possible Mechanisms in Diabetes Mellitus. Open Conference Proc J. 2014; 5: 13-9
  • 35. Take G, Karabay G, Erdogan D, Duyar I. The ultrastructural alterations in rat corneas with experimentally-induced diabetes mellitus. Saudi Med J. 2006; 27(11): 1650-5[PubMed]
  • 36. Shanmugam KR, Mallikarjuna K, Kesireddy N, Sathyavelu Reddy K. Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2011; 49(4): 893-7[DOI][PubMed]
  • 37. Goyal RK, Kadnur SV. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia. 2006; 77(3): 160-3[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments